15 May 2002
Blood serum levels of soluble forms of adhesion molecules ICAM-1 (sICAM-1)and selectin E (s-selectin E) in patients with various phases of non-Hodgkin's lymphomas.
Katarzyna Kapelko-Słowik, Stanisław Potoczek, Irena Frydecka, Dariusz Wołowiec, Donata Urbaniak-Kujda, Kazimierz KuliczkowskiMed Sci Monit 2002; 8(5): BR175-178 :: ID: 420849
Abstract
BACKGROUND: Monitoring of disease activity and effectiveness of treatmentplays an important role in curative management of patients with non-Hodgkin's lymphomas (n-HL). In thesearch for markers useful for biochemical monitoring of n-HL patients, a group of proteins called adhesionmolecules attracted attention. Particular attention has been devoted to sICAM-1 (intercellular adhesionmolecule-1). A correlation between sICAM-1 levels and histological malignancy grades and clinical stagingof n-HL, activity of the disease and tumor mass has been observed. The aim of the study was to assessthe utility of determining serum levels of selected adhesion molecules in n-HL monitoring. The studywas carried out in 60 patients with intermediate and high malignancy grade n-HL according to WorkingFormulation (anaplastic, lymphoblastic, immunoblastic, centroblastic and centroblastic-centrocytic).MATERIAL/METHODS: Soluble ICAM-1 adhesion molecule (sICAM-1) and selectin E levels were determined inthe sera of 31 newly diagnosed patients, 18 with complete remission, and 11 with relapse of the disease.The control group consisted of 15 healthy subjects. The results were expressed in ng/ml. RESULTS: sICAM1levels were similar in healthy controls and patients in the remission phase and significantly lower inpatients with diagnosed active disease and relapses. Relapses were associated with slightly lower levels(on borderline of statistical significance) than of diagnosis Serum selectin E levels, however, demonstratedno differences among patient groups or as compared with controls. CONCLUSIONS: The presented resultsindicate the utility of serum sICAM-1 level determination in assessment of activity of intermediate andhigh malignancy grade non-Hodgkin's lymphomas.
Keywords: Adolescent, Case-Control Studies, Cell Adhesion, E-Selectin, Intercellular Adhesion Molecule-1, Lymphoma, Non-Hodgkin
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952